Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma
NCT07715097
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Survivin-targeted DC Cell Injection
Sponsor
Beijing Tricision Biotherapeutics Inc